Clinical Trial Update: Predictive Utility of DASIMAR as a Prognostic Biomarker in Acute-on-chronic Liver Failure (ACLF)

View source ↗

Summary

Clinical trial update assessing the predictive utility of the DASIMAR biomarker for prognosis in acute-on-chronic liver failure due to liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• On Chronic Liver Failure

Snippet

Sponsor: University College London Hospitals | Conditions: Liver Cirrhosis | Status: UNKNOWN